James Samuel Shannon's Net Worth

$4.96 Million

Estimate Recalculated Nov 11, 2024 02:44AM EST

Who is James Samuel Shannon?

James Samuel Shannon has an estimated net worth of $4.96 Million. This is based on reported shares across multiple companies, which include Horizon Pharma plc, MANNKIND CORP, ENDOCYTE INC, and Xilio Therapeutics, Inc..

SEC CIK

James Samuel Shannon's CIK is 0001485417

Past Insider Trading and Trends

2011 was James Samuel Shannon's most active year for acquiring shares with 5 total transactions. James Samuel Shannon's most active month to acquire stocks was the month of April. 2023 was James Samuel Shannon's most active year for disposing of shares, totalling 7 transactions. James Samuel Shannon's most active month to dispose stocks was the month of August. 2010 saw James Samuel Shannon paying a total of $359,800.00 for 45,142 shares, this is the most they've acquired in one year. In 2023 James Samuel Shannon cashed out on 95,125 shares for a total of $4,071,543.64, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Horizon Pharma plc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-56.79K
$116.50
-$6,616,501.00
0
Oct 6
Form 4
+55.62%
11.85K
$12.19
$144,451.50
33.16K
Sep 29
Form 4
—
0
—
—
0
Jul 27
Form 4
+10.55%
2.03K
$111.16
-$208,869.64
21.31K
Apr 28
Form 4
+6.36%
2.56K
$98.56
-$163,412.48
42.91K
Apr 28 - Apr 29
Form 4
+20.06%
6.74K
$94.62
-$412,259.34
40.34K
Apr 29 - Apr 30
Form 4
—
0
$51.75
-$572,102.55
0
Mar 1
Form 4
+17.41%
4.98K
$61.19
-$197,092.99
33.6K
Aug 2
Form 4
+48.51%
9.35K
$35.62
-$215,180.42
28.62K
Apr 30 - May 2
Form 4
—
0
$19.32
-$356,186.05
0
Sep 12 - Sep 13
Form 4
+34.87%
4.98K
$24.64
-$79,340.80
19.27K
Aug 2
Form 4
+186.75%
9.31K
$26.54
-$159,611.56
14.29K
May 2 - May 3
Form 4
∞
4.98K
$18.18
-$58,539.60
4.98K
Aug 2
Form 4
—
0
—
—
0
May 3
Form 4
—
0
—
—
0
Aug 2
Form 3
—
0
—
—
0
No matching records found

MANNKIND CORP (MNKD) Snapshot price: $5.85

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 15
Form 4
—
0
—
—
0
May 25
Form 4
—
0
—
—
0
May 10
Form 4
—
0
—
—
0
May 20
Form 4
—
0
—
—
0
May 21
Form 4
—
0
—
—
0
May 14
Form 4/A
—
0
—
—
0
May 16
Form 4
—
0
—
—
0
May 18
Form 4
—
0
—
—
0
May 18
Form 4
+1,258.00%
11.8K
—
—
12.74K
May 21
Form 4/A
+139.79%
7.19K
—
—
12.33K
Jun 2
Form 4
—
0
—
—
0
Jun 2
Form 4
∞
5.14K
—
—
5.14K
Jun 10
Form 4
—
0
—
—
0
Jun 10
Form 4
—
0
—
—
0
Feb 24
Form 3
—
0
—
—
0
No matching records found

ENDOCYTE INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
May 26
Form 4/A
—
0
—
—
0
Feb 9
Form 4
—
0
—
—
0
Feb 9
Form 3
—
0
—
—
0
No matching records found

Xilio Therapeutics, Inc. (XLO) Snapshot price: $0.844

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Jun 13
Form 3
—
0
—
—
0
No matching records found